Insider Sale: Francesco Bianchi Disposes of 1,500 LIVN Shares

Rhea-AI Filing Summary

LivaNova director Francesco Bianchi sold 1,500 ordinary shares on 08/25/2025 at a reported price of $56.50 per share. After the sale he beneficially owned 9,028 ordinary shares, reported as direct ownership. The Form 4 was signed on behalf of the reporting person by Sarah K. Mohr, Attorney-in-Fact, on 08/27/2025. The filing discloses the transaction code S (sale) and provides the reporter's London address; no derivative transactions or amendments are reported.

Positive

• Form 4 discloses the transaction with specific details: sale date, number of shares, and price.
• The filing is signed by an attorney-in-fact (Sarah K. Mohr) indicating authorized submission.
• Post-transaction beneficial ownership is reported as 9,028 direct shares, providing clear ownership figures.

Negative

• The reporting director sold 1,500 ordinary shares, reducing direct ownership.
• The filing does not indicate whether the sale was made under a pre-existing plan (no 10b5-1 notation present in the provided content).

Insights

Securities Analyst

TL;DR: A director executed a routine equity sale of 1,500 shares, leaving 9,028 shares owned; disclosure appears complete and routine.

The Form 4 reports a single non-derivative transaction: a sale of 1,500 ordinary shares at $56.50 on 08/25/2025, reducing direct beneficial ownership to 9,028 shares. No options, derivatives, or additional amendments are included. For investors, this is a standard insider sale with no accompanying commentary or linked corporate event in the filing itself. The document is properly signed by an attorney-in-fact on 08/27/2025.

Corporate Governance Expert

TL;DR: Disclosure meets Section 16 requirements; the sale is documented and signed, suggesting procedural compliance.

The filing indicates compliance with reporting rules: the reporter is identified as a director and the transaction uses code S for sale. The form lists direct ownership post-transaction and contains an authorized signature. The filing does not show any coordinated plan (no 10b5-1 box checked in the content provided) nor any derivative holdings, so governance implications are limited to routine insider liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bianchi Francesco

(Last) (First) (Middle)

20 EASTBOURNE TERRACE

(Street)

LONDON X0 W2 6LG

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LivaNova PLC [ LIVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/25/2025		S		1,500	D	$56.5	9,028	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Sarah K. Mohr, Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LivaNova director Francesco Bianchi report on Form 4 (LIVN)?

The Form 4 reports a sale of 1,500 ordinary shares on 08/25/2025 at a price of $56.50 per share.

How many LivaNova (LIVN) shares does Francesco Bianchi own after the sale?

The filing shows 9,028 ordinary shares beneficially owned following the reported transaction.

When was the Form 4 for the LIVN transaction signed?

The Form 4 signature block shows it was signed by Sarah K. Mohr, Attorney-in-Fact on 08/27/2025.

Was the transaction in LivaNova stock a derivative or an ordinary share transaction?

It was a non-derivative transaction involving ordinary shares (a direct sale).

Does the Form 4 show any derivative holdings or amendments for this reporting person?

No. The provided Form 4 contains no derivative securities reported and no amendment date beyond the original transaction.